Introducing
EMIR&A is a network of facilities providing the scientific community with a set of advanced accelerators and in situ instruments with unique performances, dedicated to irradiation and analysis of molecules and materials.
Submit a proposal
Dear all,
The access to your USER SPACE is available again. You can now submit your proposals.
——————————————————————-
Before submission, please contact the platform to discuss the feasibility of the experiment
News
Latest news and jobs
News
News from EMIR&A WEB SITE
Dear colleagues,
The access to your USER SPACE is available again. You can now submit your proposals.
The site will remain open until November 3 for the submission of projects.
We sincerely apologize for the inconvenience.
The EMIR&A team
News
EMIR&A Call for proposal 2025 is now Open
Dear all,
We are pleased to announce that the EMIR&A 2025 Call for Proposals is now open. You have until October 20 to submit your proposals on https://emira.in2p3.fr/ from your personal user space.
We would like to take this opportunity to announce the arrival of the AIFIRA platform (from LP2I Bordeaux) in the EMIR&A network. In 2025, AIFIRA will be providing beam time for ion beam analysis experiments, available with the pump priming procedure.
Best regards,
The EMIR&A team
13/09/2024
Facilities
EMIR&A facilities
The EMIR&A facilities are complementary to one another, regarding the accelerated particles, the available energies and the available instrumentation. They are distributed on 6 sites.
About
Emir&a
In brief
EMIR&A is also a Research Infrastructure, listed in the Roadmap 2021-2025 of the French Ministry for Higher Education, Research, and Innovation
Learn more
Study of Irradiation and radiolysis effects in solids, in situ physical and chemical characterizations of materials, including ion beam analysis
Learn more
EMIR&A: a structure with international implications
EMIR&A is composed of 15 accelerators, distributed over 11 platforms located on 6 sites. Over the 2017-2020 period, EMIR&A users come on average for 2/3 from French laboratories and for 1/3 from foreign laboratories.
